Pomalidomide Impurity 27 | CAS 498-25-9 - Request Quote
Pomalidomide Impurity 27
| SZ CAT No: | SZ-P055047 |
| CAS No | 498-25-9 |
| Mol.F. | C4H8N2O3 |
| Mol.Wt. | 132.1 |
| Inv. Status | Under Synthesis |
| Rel. CAS No | 1955493-50-1 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pomalidomide Impurity 27 is chemically 3,4-diamino-4-oxobutanoic acid. Pomalidomide Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Pomalidomide Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pomalidomide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 498-25-9
Purchase 498-25-9
Order 498-25-9
Enquire 498-25-9
price of 498-25-9
498-25-9 Supplier
498-25-9 Manufacturer
498-25-9 Exporter
buy high quality Pomalidomide Impurity 27
Purchase Pomalidomide Impurity 27
Pomalidomide Impurity 27 suppliers
Pomalidomide Impurity 27 manufacturers
Pomalidomide Impurity 27 price
Order Pomalidomide Impurity 27
Enquire Pomalidomide Impurity 27
Pomalidomide Impurity 27 cost
Pomalidomide Impurity 27 Supplier
Pomalidomide Impurity 27 Distributor
Pomalidomide Impurity 27 for Method Validation
Pomalidomide Reference Standard
Pomalidomide Impurity 27 for ANDA Filing
Pomalidomide Impurity 27 for Forced Degradation Studies
Pomalidomide Impurity 27 Identification Standards
Pomalidomide Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.